Paltech Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series 2

  • Latest Deal Amount
  • $10.8M

  • Investors
  • 1

Paltech General Information

Description

Developer of a laparoscopically implantable medical device designed to serve diabetes patients. The company's device utilizes a patient molecular expression pattern that targets the precise receptor on the right organ, enabling users to apply early treatment to avoid complications related to type-two diabetes.

Contact Information

Website
www.paltech.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5 Avenue du Général Tripier
  • 75007 Paris
  • France
+33 06
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 5 Avenue du Général Tripier
  • 75007 Paris
  • France
+33 06

Paltech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Paltech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series 2) 25-Jul-2024 $10.8M Completed Pre-Clinical Trials
2. Early Stage VC 04-Jul-2023 Completed Pre-Clinical Trials
1. Accelerator/Incubator 30-Nov-2021 $1.42M $1.42M Completed Product In Beta Test
To view Paltech’s complete valuation and funding history, request access »

Paltech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
Ordinary Shares 2,900 $1.086367 $38.02 $38.02 1x $38.02 1.99%
To view Paltech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Paltech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Paltech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Impact Venture Partners Venture Capital Minority
To view Paltech’s complete investors history, request access »

Paltech FAQs

  • When was Paltech founded?

    Paltech was founded in 2020.

  • Where is Paltech headquartered?

    Paltech is headquartered in Paris, France.

  • What is the size of Paltech?

    Paltech has 5 total employees.

  • What industry is Paltech in?

    Paltech’s primary industry is Drug Delivery.

  • Is Paltech a private or public company?

    Paltech is a Private company.

  • What is Paltech’s current revenue?

    The current revenue for Paltech is .

  • How much funding has Paltech raised over time?

    Paltech has raised $13.8M.

  • Who are Paltech’s investors?

    Impact Venture Partners has invested in Paltech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process